other material
confidence high
sentiment neutral
materiality 0.50
Zivo Bioscience adopts staggered board, eliminates shareholder written consent
Zivo Bioscience, Inc.
- Board approved Second Amended and Restated Bylaws effective June 30, 2022.
- Creates three-class staggered board; only one class elected per annual meeting after initial election.
- Eliminates stockholder ability to take action by written consent.
- Only the Board may appoint directors to fill vacancies or change the number of directors.
- Adds modernizing provisions for electronic meetings and access to corporate records.